Member Info for Servalan

Biotechs being hammered today across the board, XBI well down

Hysterical levels of pumping here now. Yes, it is good news but it still remains a volatile, AIM UK biotech. It does not warrant dozens of posts a day from one individual.

Another round of distractions so Bibi can continue his invasion of Lebanon. The Greater Israel project continues apace, completely ignored by the media, of course.

Rx NHS England Mar 2026: £183,070 (Mar 2025: £121,700) that's a 50% yoy increase !

(open prescribing dot net)

Pumpingtoday - where's the M O N E Y ????

I hope someone with deep pockets and great lawyers can get to the bottom of all this. Whole thing stinks to high heaven.

Typical of this company, pump up before nothing news. Watch the pumpers all disappear now. Yet another study. We KNOW it works, get it sold! Zero commercial value, yet again.

As long as Israel controls the US gvt there will be no peace. It is cover for their Lebanon clearance.

It's AIM, Africa and now the Chinese. A perfect trinity of trouble. May as well set fire to your money. Amounts to the same thing.

Nobody cares about either of you, get a room. Better still, get a life.

"They could get project finance easily because they are so big.." then why haven't they?

Just go away will you.

Come on EerEyeAm, what do you have to say about all this, andJack?

I have contacted Investor Relations about the constant UBS adjustments before. The answer is always the same, it is a client of UBS moving their holdings around internally (within UBS) and they said they would speak to them about it. It is not UBS directly buying or selling. What interest would they have in a tiny biotech on life support? The lights are going out here soon enough fi they don't bring in some money. One more to add to the list of AIM biotechs flushed down the toilet.

It isn't just about risk for me, more about opportunity cost. The sp has gone nowhere in 3 years. The very definition of dead money. I'm not a trader and prepared to wait a long time but my patience is not endless.

I'll just add it to the very, very long list of British biotechs treated like garbage on AIM. If this was listed in the US it would be 10x more. So many stocks can remain massively undervalued in the UK for years.

They are most certainly not our "friends" at the moment. The money I have put into this farce could have been in Ceres, amongst many others motoring ahead in the last 6 weeks. They had many months up to the rat to sort this all out.

I won't be adding any more, I have enough. At some point you have to start seeing a sustained share price rise otherwise what is the point. Holding Shield shares is not a hobby.

After all the progress the last year or so I never thought we would be back down under 7p again. Its an AIM biotech so always going to be thrown around but I can't let this sit here and lose on opportunity cost. Time to revisit why I am invested here again.

Don't know what is provoking this reaction but it's another example of one step forward, two steps back with Shield. It can't be just a few performance shares for leadership?

@ceejay101 I'll try! there are some great minds with a lot of experience on this board when they aren't squabbling. We all want the same thing here.